Peer-influenced content. Sources you trust. No registration required. This is HCN.
TheBodyPro
The “Effectiveness of PrEPTECH” trial reveals telehealth’s potential and challenges in initiating and sustaining PrEP adherence among at-risk groups, emphasizing the necessity for integrated community support in healthcare strategies.
Infectious Diseases April 22nd 2024
MDLinx
In the evolving landscape of erectile dysfunction treatment, alternative therapies offer hope beyond first-line medications. Current research and guidelines underscore the importance of comprehensive patient evaluation and the cautious integration of new therapeutic options.
Family Medicine/General Practice April 16th 2024
Cleveland Clinic Journal of Medicine
Microscopic colitis, often masked in routine diagnostic evaluations, necessitates a histological approach for accurate diagnosis. The disease’s association with specific medications underscores the need for careful patient medication reviews.
Gastroenterology April 15th 2024
GoodRx Health
Urine color can serve as a valuable diagnostic tool, offering insights into a patient’s hydration level and potential underlying health issues. Understanding these variations is essential for timely and accurate diagnosis.
Urology April 8th 2024
In a significant stride toward personalized medicine, researchers have utilized AI to unveil two distinct evotypes of prostate cancer, heralding a new era in the disease’s diagnosis and management. This pivotal discovery opens doors to tailored treatment strategies, potentially mitigating the adverse effects of over-treatment in prostate cancer.
Hematology/Oncology March 25th 2024
In the battle against recurrent herpes simplex virus infections, chronic suppressive therapy emerges as a pivotal strategy, diminishing both the physical burden of outbreaks and the psychological weight of potential transmission.
Dermatology March 20th 2024